Iovance Biotherapeutics: cell therapy company utilizing proprietary autologous tumor infiltrating lymphocytes (TILs) to attack solid tumors. Conducting pivotal stage trial in metastatic melanoma and cervical cancer, with BLA expected 2020, Additional company-sponsored trials: head & neck cancer, non-small cell lung cancer, and earlier lines in melanoma. IST collaborations in ovarian cancer, bladder cancer, sarcomas, adenocarcinoma, and pancreatic cancer.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
USA
Clinical Stage
Registration Stage
Disease Space
Immuno-Oncology, Immunotherapy
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
1B +
Therapeutic Modalities
Cell Therapy
Website:
Address:
999 Skyway Road
Suite 150
San Carlos, CA 94070
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Upcoming Company Event Participation

Solebury Trout Management Access: SF 2020

San Francisco, CA, United States, January 13 – January 16, 2020

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2019 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.